Correction to: Journal of Cancer Research and Clinical Oncology (2010) 136:1201–1211 10.1007/s00432-010-0770-6
In Fig. 2 of this article, incorrect data was originally displayed in panels A-F. The published incorrect version and the corrected version of figure 2 are given below.
Corrected version:
Fig. 2.
Microvascular density of Lewis lung carcinoma decreased by rh-endostatin. When the implanted tumor reached a volume of about 100 mm3, rh-endostatin was given 5 mg/kg subcutaneously for consecutive 7 days with normal saline as control. On days 3, 6, and 9, mice (n = 5) were killed and tumor samples were stained by anti-CD31 antibody. a–c Typical photographs represented the microvessels in Lewis lung carcinoma in control group on days 3, 6, and 9, respectively. d–f Typical photographs represented the microvessels in Lewis lung carcinoma in rh-endostatin group on days 3, 6, 9, respectively. Scale bar 25 μm. g Histogram of mean microvascular density at different time points. Microvascular density was reduced by rh-endostatin and the difference was significant on day 9 (p = 0.013), bars SEM. *p < 0.05
The original article has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


